Inhibition of p38 MAP kinase by utilizing a novel allosteric binding site
Boehringer Ingelheim (Japan) · Boehringer Ingelheim (Brazil) · +2 more institutions
Indexed incrossrefdatacitepubmed
Abstract
No abstract available for this paper.
Citation impact
833
total citations
- FWCI
- 11.72
- Percentile
- 100%
- References
- 28
Citations per year
Authors
11- CPChristopher PargellisCorresponding
Boehringer Ingelheim (Japan), Boehringer Ingelheim (Brazil), Boehringer Ingelheim (United States)
- LTLiang TongCorresponding
Columbia University, Boehringer Ingelheim (United States)
- LCLaurie Churchill
Boehringer Ingelheim (United States)
- PFPier F. Cirillo
Boehringer Ingelheim (United States)
- TDThomas D. Gilmore
Boehringer Ingelheim (United States)
Topics & keywords
Topics
Keywords
- Allosteric regulation
- Binding site
- Allosteric enzyme
- Kinase
- Biochemistry
- Chemistry
- Protein kinase A
- Conformational change
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.